• Explore /
  • Poster
  • / DNA damage repair (DDR) pathway alteration in advanced renal cell carcinoma (RCC) is association with good progression-free survival with tyrosine kinase inhibitor (TKI) therapy.

DNA damage repair (DDR) pathway alteration in advanced renal cell carcinoma (RCC) is association with good progression-free survival with tyrosine kinase inhibitor (TKI) therapy.

Abstract Poster

Authors

null

Wei Zhai

Department of Urology, Renji Hospital, School of Medicine in Shanghai Jiao Tong University, Shanghai, China

Wei Zhai , Junyun Wang , Ning He , Jiale Zhou , Jianfei Wang , Yizheng Xue , Zhaolin Yang , Yonghui Chen , Jin Zhang , Jiwei Haung , Wen Kong , Yiran Huang , Wei Xue

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 346)

DOI

10.1200/JCO.2021.39.6_suppl.346

Abstract #

346

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Kento Morozumi

First Author: Justin Nathaniel Malinou

First Author: Constance Thibault

First Author: Giacomo Nuvola